BRKR250117C45000
- 6.20
- 0.000.00%
Bruker Corp Newsroom
Bruker Analyst Ratings
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $72
Wells Fargo Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $75
TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Maintains Target Price $70
Citi Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $75
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $80
Guggenheim Initiates Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $72
Bruker Initiated at Buy by Guggenheim
Bruker Is Maintained at Buy by B of A Securities
Bruker Analyst Ratings
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $80
Bruker Coverage Assumed by UBS at Neutral Vs Previous Rating of Buy
UBS Downgrades Bruker Corp(BRKR.US) to Hold Rating, Cuts Target Price to $66
UBS Downgrades Bruker to Neutral From Buy, Cuts Price Target to $66 From $102
Goldman Sachs Upgrades Bruker Corp(BRKR.US) to Hold Rating
Bruker Price Target Maintained With a $60.00/Share by Goldman Sachs
Bruker Raised to Neutral From Sell by Goldman Sachs
Bruker Analyst Ratings
Goldman Sachs Upgrades Bruker to Neutral, Maintains Price Target to $60
Bruker Price Target Cut to $69.00/Share From $75.00 by Barclays